Carver Bio Plants Seed to Treat Viral Threats with CRISPR Cas13

With a distinct take on CRISPR technology, Carver Biosciences secured seed financing to support the development of RNA-targeting gene therapies aimed at RNA-based respiratory infectious diseases.